Clinical Studies of Histone Deacetylase InhibitorsH. Miles Prince, Simon J. Harrison, Mark Bishton|Clinical Cancer Research|2009Cited by 356
Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor–induced thrombocytopeniaMark Bishton, Ricky W. Johnstone, Nicole M. McLaughlin et al.|Blood|2011Cited by 134
Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicityToby A. Eyre, Chris S.R Hatton, Amy A. Kirkwood et al.|British Journal of Haematology|2019Cited by 65